Ir para o conteúdo principal

Grafa News and Videos — Page 1115

Destaques de Grafa

Grafa

IDEAYA announces positive Phase 2/3 data in metastatic uveal melanoma

IDEAYA Biosciences (NASDAQ:IDYA) and Servier reported breakthrough topline results today from the Phase 2/3 OptimUM-02 trial, demonstrating that the combination of darovasertib and crizotinib significantly improved outcomes for patients with first-line HLA-A*02:01-negative metastatic uveal melanoma (MUM).

Leia mais: IDEAYA announces positive Phase 2/3 data in metastatic uveal melanoma

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas